Synergy Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Synergy Pharmaceuticals ( SGYP) is a development-stage biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. This stock is trading up 6.9% at $5.26 in recent trading.

Today's Range: $5.00-$5.43

52-Week Range: $1.86-$5.24

Volume: 136,000

Three-Month Average Volume: 60,027

>>10 Stock Picks From a Small-Cap Specialist

From a technical perspective, SGYP is moving sharply to the upside today on above-average volume. This move has now pushed SGYP into breakout territory since its moving above some past overhead resistance at $5.24.

Traders should continue to look for long-biased trades in SGYP as long as it's trending above $5.24 with strong upside volume flows. I would consider volume near or above 60,027 shares as strong. A potential target to the upside is $6 to $6.30 as long as SGYP can continue its trend above 5.24.

If you liked this article you might like

Winning FDA Approval Isn't Always a Win

Will Allergan's Deal With Tribe Hold Up?

2 Small Biotechs Under $5 May Be Bargains

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)